Different mutational characteristics of TSG in cell lines and surgical specimens

Autor: Jolanta Zieba, Grzegorz Bieniek, Mateusz Banaszczyk, Piotr Rieske, Marta Winiecka-Klimek, Sylwester Piaskowski, Marcin Pacholczyk, Ewelina Stoczynska-Fidelus, Michał Bieńkowski
Rok vydání: 2014
Předmět:
Zdroj: Tumour Biology
ISSN: 1423-0380
1010-4283
DOI: 10.1007/s13277-014-2444-5
Popis: One of the most crucial concerns of cancer research pertains to the differences between the neoplastic cells in tumor specimens in vivo and their counterparts in cell lines. The huge amount of results deposited in cancer genetic databases allows to address this issue from a wider perspective. Our analysis of the Sanger Institute Catalog Of Somatic Mutations In Cancer (COSMIC) database v61 showed a lower percentage of homozygous mutations in a group of tumor suppressor genes in surgical samples (in vivo) in comparison to their frequency in cell lines (in vitro). Similarly, the mutations resulting in the lack of protein (e.g., nonsense mutations or whole gene deletions) of several tumor suppressor genes (TSGs) were more frequently observed in vitro than in vivo. In this article, we suggest two potential explanations of these data. Firstly, TSG heterozygous mutations resulting in the modified protein (e.g., missense mutations) may be gradually (when the specific molecular context is achieved) changed to homozygous mutations resulting in the lack of protein during carcinogenesis. Secondly, among different independent pathways of tumorigenesis, those leading to homozygous nonsense mutations are characteristic for cells which are more efficiently stabilized in vitro. To conclude, these observations may be interesting for researchers working with cell line in vitro models illustrating the extent to which they reflect the tumors in vivo. Electronic supplementary material The online version of this article (doi:10.1007/s13277-014-2444-5) contains supplementary material, which is available to authorized users.
Databáze: OpenAIRE
Externí odkaz: